Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Katherine Wiegand, MEng

The Emmes Company

Disclosure(s): No financial relationships to disclose

Poster(s):

233 - Safety of Ceftazidime-Avibactam (CZA) in Combination with Aztreonam (ATM) in a Phase I, Open-Label Study in Healthy Adult Subjects (COMBINE)
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET